| Old Articles: <Older 29561-29570 Newer> |
|---|
 |
The Motley Fool
April 9, 2008
Brian Orelli |
Repligen Gets a Surprise Infusion of Cash Bristol-Myers Squibb agrees to pay Repligen royalties in their patent-infringement lawsuit.   |
The Motley Fool
April 9, 2008
Brian Orelli |
Russia Approves an Unproven Treatment Antigenics gains approval of Oncophage in Russia, making it the first pharmaceutical to gain approval of any cancer vaccine. |
The Motley Fool
April 9, 2008
David Lee Smith |
Alcoa's Where It Wants to Be Alcoa's earnings release is perhaps a little more complicated than first appearances would indicate. |
The Motley Fool
April 9, 2008
Tim Beyers |
Don't Fear the Finjan Finjan Software has asked a court to bar Secure Computing from selling products it claims it has the patent on. But the fight isn't over yet. |
The Motley Fool
April 9, 2008
Alyce Lomax |
Who's That Mermaid? Starbucks tries to make a splash, introducing its new Pike Place "everyday" brew. |
The Motley Fool
April 9, 2008
Rich Smith |
Philips Tunes Out America The Dutch electronics giant decides it won't make or sell LCD television sets for the U.S. |
The Motley Fool
April 9, 2008
Rick Aristotle Munarriz |
Bill Miller Takes On Microhoo Should Yahoo! walk if Microsoft lowers its buyout offer later this month? |
The Motley Fool
April 9, 2008
Tim Beyers |
Be Bold -- Especially Now What works for the best investors can work for you too. |
The Motley Fool
April 9, 2008
Rick Aristotle Munarriz |
Goodbye, Iomega Iomega is acquired by EMC for $213 million. |
The Motley Fool
April 9, 2008
Anders Bylund |
Foolish Forecast: American Problems Won't Bother GE In advance of General Electric's earnings, let's take a look at how the company did last quarter, and how it compares to some of its peers and competitors. |
| <Older 29561-29570 Newer> Return to current articles. |
